Amy Stillings

Amy Stillings

Auto-generated profile, based on publicly available information

Amy Stillings

Department of Pediatrics, University of California, San Diego, San Diego, CA

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 October 2022 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
CAChristina Abrams
Christina Abrams
JJJulie Jaffray
Julie Jaffray
ASAmy Stillings
Amy Stillings
BBBrian Branchford
Brian Branchford
GYGuy Young
Guy Young
SPStephanie Prozora
Stephanie Prozora
A rise in hospital‐acquired venous thromboembolism (HA‐VTE) in children has led to increased awareness regarding VTE prophylaxis and risk assessment. Despite no consensus exists regarding these practices in pediatrics. To describe common practices in VTE prophylaxis, VTE risk assessment models, and anticoagulation dosing strategies in pediatric hospitals that are members of the Children's Hospital Acquired Thrombosis (CHAT) Consortium. An electronic survey of 44 questions evaluating practices surrounding pediatric HA‐VTE risk assessment and prevention was distributed between August 9, 2021, and August 30, 2021, to the primary investigators from the 32 institutions within the CHAT Consortium. The survey response rate was 100% (n = 32). In total, 85% (n = 27) of the institutions assess HA‐VTE, but only 63% (n = 20) have formal hospital guidelines. Within the institutions with formal guidelines, 100% (n = 20) include acute systemic inflammation or infection and presence of a central venous catheter (CVC) as risk factors for VTE. Pharmacologic prophylaxis is prescribed at 87% (28) of institutions, with enoxaparin being the most frequent (96%, n = 27). Variability in responses persisted regarding risk factors, risk assessment, thromboprophylaxis, dosing of prophylactic anticoagulation or anticoagulant drug monitoring. A majority of providers were comfortable providing thromboprophylaxis across all age groups. In addition, the global coronavirus disease 2019 increased the providers' use of prophylactic anticoagulation 78% (n = 25). Practices among institutions are variable in regard to use of HA‐VTE prophylaxis, risk assessment, or guideline implementation, highlighting the need for further research and a validated risk assessment model through groups like the CHAT Consortium.

19 February 2026 in Blood
Verified
Journal Article
Closed access
JJJulie Jaffray
Julie Jaffray
BBBrian Branchford
Brian Branchford
MAMaua M. Alleyne
Maua M. Alleyne
EAErnest K. Amankwah
Ernest K. Amankwah
EFE. Vincent S. Faustino
E. Vincent S. Faustino
JWJordan M Wright
Jordan M Wright
Critically ill children are at a high risk for hospital-associated venous thromboembolism (HA-VTE). Developing a validated risk assessment model (RAM) to identify children who may benefit from thromboprophylaxis is essential. We aimed to prospectively validate the Children’s Healthcare Advancements in Thrombosis (CHAT)–intensive care unit (ICU) VTE RAM (CHAT-ICU RAM), containing 5 clinically significant variables: central venous catheter, immobility, congenital heart disease, autoimmune or inflammatory conditions, and hospital stay of ≥3 days in a multicenter cohort study. Randomly selected patients aged 0 to 21 years admitted to a pediatric ICU (PICU) at 32 institutions were monitored through medical record review for HA-VTE. Discrimination was assessed using the area under the receiver operating characteristic (AUROC) curve. Calibration was assessed using calibration plots. Complete-case and imputed analyses were performed, and model risk scores were generated along with posttest probability. The RAM was validated in 4674 patients, with an AUROC of 0.71, a calibration slope of 1.0, and an intercept of 1.81 × 10−5. The AUROC for the imputed model was 0.69 with a calibration slope of 1.03 and an intercept of 1.22 × 10−3. Calculated risk scores were 1 or 2 for each variable in the RAM with a total risk score ranging from 0 to 6. The estimated probability of developing HA-VTE ranged from 1% to 17.4% depending on the total score. In conclusion, the CHAT-ICU RAM has good discriminatory validity, is well calibrated, and reliably identifies children in the PICU at high and low risk of HA-VTE.

13 October 2022 in Research and Practice in Thrombosis and Haemostasis
Verified
Journal Article
Open access
ESElizabeth T. Stephens
Elizabeth T. Stephens
ANAnh Thy H. Nguyen
Anh Thy H. Nguyen
JJJulie Jaffray
Julie Jaffray
BBBrian Branchford
Brian Branchford
EAErnest K. Amankwah
Ernest K. Amankwah
JFJohn H. Fargo
John H. Fargo
Surgery is a known risk factor for hospital‐acquired venous thromboembolism (HA‐VTE) in children. To assess whether the odds of HA‐VTE differs across six anatomic sites of noncardiac surgery and to identify risk factors for HA‐VTE in these children. This was a multicenter, case–control study. Anatomic sites of surgery and risk factors for HA‐VTE were collected on hospitalized pediatric patients who had undergone a single noncardiac surgery and developed HA‐VTE (cases), and those who did not develop HA‐VTE (controls), via the Children's Hospital‐Acquired Thrombosis (CHAT) Registry. Logistic regression estimated the odds ratio (OR) and 95% confidence intervals (CIs) between six anatomic sites of surgery and 16 putative HA‐VTE risk factors. Variables with a p value of 0.10 or less in unadjusted analyses were included in adjusted models for further evaluation. The final model used backward selection, with a significance level of 0.05. From January 2012 to March 2020, 163 cases (median age, 5.7 years; interquartile range [IQR], 0.3–14.2) and 208 controls (median age of 7.5 years; IQR, 3.7–12.9) met our criteria. There was no statistically significant increased odds of VTE among the types of noncardiac surgery. In the final adjusted model, central venous catheter (CVC; OR, 14.69; 95% CI, 7.06–30.55), intensive care unit (ICU) stay (OR, 5.31; 95% CI, 2.53–11.16), and hospitalization in the month preceding surgery (OR, 2.75; 95% CI, 1.24–6.13) were each independently significant risk factors for HA‐VTE. In children undergoing noncardiac surgery, placement of CVCs, admission/transfer to the ICU, or hospitalization in the month prior to surgery were positively associated with HA‐VTE.